GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
28 hedge funds and large institutions have $803K invested in Aevi Genomic Medicine Inc in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$201K | |
| 2 | +$49.2K | |
| 3 | +$47.9K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14K |
Top Sellers
| 1 | -$3.85M | |
| 2 | -$2.77M | |
| 3 | -$141K | |
| 4 |
Millennium Management
New York
|
-$43K |
| 5 |
AMCA
Arthur M. Cohen & Associates
Northbrook,
Illinois
|
-$38.6K |